Home / Market News / $XNCR
benzinga Corporate Catalyst Impact 55/100 ● positive

Truist Securities Reiterates Buy on Xencor, Raises Price Target to $29

Sep 28, 2026, 3:18 PM UTC · Primary ticker $XNCR

Truist Securities analyst Gregory Renza reiterated a Buy rating on Xencor (XNCR) and increased its price target from $27 to $29. This indicates a continued positive outlook from the analyst, suggesting potential upside for the stock.

Truist Securities analyst Gregory Renza reaffirmed a 'Buy' rating for Xencor (XNCR) and raised the price target from $27 to $29. This action signals a strengthened conviction in the company's prospects by a prominent financial institution. For traders, this could lead to short-term positive sentiment and potentially increased buying activity, as the higher price target suggests an expected appreciation in the stock's value. While not a major corporate event, analyst upgrades and price target increases can influence investor perception and provide a positive catalyst, particularly for growth-oriented biotechnology stocks. The long-term implications depend on Xencor's fundamental performance aligning with this optimistic analyst view.

$XNCR positive Analyst price target increase
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.